新型コロナウイルス感染症ワクチンのインド市場2021-2027

■ 英語タイトル:India COVID-19 Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027)

調査会社DPI Research社が発行したリサーチレポート(データ管理コード:DPI21SP005)■ 発行会社/調査会社:DPI Research
■ 商品コード:DPI21SP005
■ 発行日:2021年2月
■ 調査対象地域:インド
■ 産業分野:医薬品
■ ページ数:80
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD1,190 ⇒換算¥176,120見積依頼/購入/質問フォーム
Corporate UserUSD1,890 ⇒換算¥279,720見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
DPI Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[新型コロナウイルス感染症ワクチンのインド市場2021-2027]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本調査レポートでは、新型コロナウイルス感染症ワクチンのインド市場について調査・分析を行い、エグゼクティブサマリー、イントロダクション、市場規模・分析、ワクチン接種者数、ワクチン投与数、市場成長・阻害要因、最近の出来事、インドにおけるワクチン開発、主要市販ワクチン、ワクチン実施におけるインド省庁の役割、ワクチン用デジタルプラットフォーム「Co-WIN」、市場主要取引、主要企業情報、新生参入企業情報などの項目をまとめております。

India’s COVID-19 vaccines market is anticipated to grow over US$ 2.3 Billion by 2027 with an impressive CAGR of more than 25% during the forecast period.
The prominent factors that are expected to contribute to the growth of the Indian COVID-19 vaccines market during the forecast period:

• Approval/launches of the New Vaccines
• Rising focus on immunization programs
• Increasing government support for the vaccine development

“India COVID-19 Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027)” is based on an inclusive study of the entire India COVID-19 vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the India COVID-19 vaccines market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2021 – 2027.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends, the number of persons being vaccinated, and doses administered of the COVID-19 vaccines in the Indian Market. The report also explores a detailed analysis of the introduction of the COVID-19, prevention, and vaccines for COVID-19 in the Indian Market.

The report also delivers a detailed assessment of the latest happenings in the Indian COVID-19 vaccines market. It also discovers a comprehensive investigation of the development and key marketed COVID-19 vaccines in India.

The report also offers detailed information about the roles of different Indian ministries/departments in COVID-19 vaccine implementation and the COVID-19 vaccine intelligence network (Co-WIN).

The report also tracks and analyses competitive developments, including collaboration, partnerships, exclusive and licensing agreements, new vaccine developments, and R&D activities in the market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.

The report concludes with the profiles of the key players in the Indian COVID-19 vaccines market. The key players are evaluated on various parameters such as business overview, COVID-19 vaccines portfolio, promising vaccines in the clinical development, and recent development.

The Major Companies Dominating this Market for their Products, Services, and Continuous Product Developments are:

• Bharat Biotech International Limited
• Serum Institute of India
• Zydus Cadila
• Biological E. Limited
• Gennova Biopharmaceuticals Limited
• Dr. Reddy’s Laboratories Ltd.

Report Scope:

• The Market Size of the India COVID-19 Vaccines Market with Six Years Forecast
• Scrutinizes India’s Number of Persons Vaccinated with COVID-19 Vaccines with Six Years Forecast
• Covers a Complete Analysis of the India COVID-19 Vaccines Doses Administered with Six Years Forecast
• Detailed Insights of the Introduction, Prevention, and Vaccines for COVID-19
• Delivers a Latest Happenings in the India COVID-19 Vaccines Market
• Extensive Coverage of the COVID-19 Vaccines Development in India
• Delivers Inclusive Insights on the Key Marketed Vaccines for COVID-19 in India
• An Insightful Investigation has been done on Promising COVID-19 Vaccines in the Clinical Development
• Reviews Roles of Different Indian Ministries/Departments in COVID-19 Vaccines Implementation
• Examines the Key Development of COVID-19 Vaccine Intelligence Network (Co-WIN)
• Investigates the Key Growth Drivers and Restraints of the India COVID-19 Vaccines Market
• Provides Key Trends with Respect to Collaboration, Partnership Deals, and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, and Recent Development
• An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

*** レポート目次(コンテンツ)***

1. Executive Summary

2. Introduction: COVID-19, Prevention and Vaccines
2.1 About COVID-19
2.2 Prevention of COVID-19
2.3 Vaccines for COVID-19

3. India COVID-19 Vaccines Market Size and Analysis (2021 – 2027)

4. India Number of Persons Vaccinated with COVID-19 Vaccines (2021 – 2027)

5. India Number of Doses Administered with COVID-19 Vaccines (2021 – 2027)

6. Key Market Drivers and Inhibitors of the India COVID-19 Vaccines Market
6.1 Market Drivers
6.2 Market Inhibitors

7. Latest Happenings in the India COVID-19 Vaccines Market

8. COVID-19 Vaccines Development in India

9. Key Marketed Vaccines for COVID-19 in India

10. Roles of Different Indian Ministries/Departments in COVID-19 Vaccines Implementation

11. COVID-19 Vaccine Intelligence Network (Co-WIN): The Digital Platform

12. Major Deals and Agreement Happenings in the India COVID-19 Vaccines Market
12.1 Collaboration Deals
12.2 Partnership Deals
12.3 Licensing Agreement

13. Key Players Analysis
13.1 Bharat Biotech International Limited
13.1.1 Business Overview
13.1.2 COVID-19 Vaccine Portfolio
13.1.3 Promising COVID-19 Vaccine in the Clinical Development
13.1.4 Recent Development
13.2 Serum Institute of India
13.2.1 Business Overview
13.2.2 COVID-19 Vaccine Portfolio
13.2.3 Promising COVID-19 Vaccines in the Clinical Development
13.2.4 Recent Development

14. Emerging Players Analysis
14.1 Zydus Cadila
14.1.1 Business Overview
14.1.2 Promising COVID-19 Vaccine in the Clinical Development
14.1.3 Recent Development
14.2 Biological E. Limited
14.2.1 Business Overview
14.2.2 Promising COVID-19 Vaccine in the Clinical Development
14.2.3 Recent Development
14.3 Gennova Biopharmaceuticals Limited
14.3.1 Business Overview
14.3.2 Promising COVID-19 Vaccine in the Clinical Development
14.3.3 Recent Development
14.4 Dr. Reddy’s Laboratories Ltd.
14.4.1 Business Overview
14.4.2 Promising COVID-19 Vaccine in the Clinical Development
14.4.3 Recent Development

List of Tables:

Table 1–1: Phases of the Vaccine Development
Table 1–2: Progress on COVID-19 Vaccine Development
Table 7–1: Indian landscape of COVID-19 Vaccines under Development
Table 12–1: Bharat Biotech International Limited Promising Coronavirus Vaccines in the Clinical Development
Table 12–2: Serum Institute of India Promising Coronavirus Vaccines in the Clinical Development
Table 12–3: Cadila Healthcare Ltd. Promising Coronavirus Vaccines in the Clinical Development
Table 12–4: Biological E. Limited Promising Coronavirus Vaccines in the Clinical Development
Table 12–5: Gennova Biopharmaceuticals Limited Promising Coronavirus Vaccines in the Clinical Development
Table 12–6: Dr. Reddy’s Laboratories Ltd. Promising Coronavirus Vaccines in the Clinical Development

List of Figures:

Figure 8–3: India COVID-19 Vaccines Market Size & Analysis (Million US$),2021 – 2027
Figure 8–1: India Number of Persons Vaccinated with COVID-19 Vaccines (Million), 2021 – 2027
Figure 8–2: India Number of Doses Administered with COVID-19 Vaccines (Million), 2021 – 2027


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DPI21SP005 )"新型コロナウイルス感染症ワクチンのインド市場2021-2027" (英文:India COVID-19 Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027))はDPI Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。